glp-1 news 2025 november Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Receptor Agonist Market Size

Weight Loss and Obesity Treatment In addition to their role in managing type 2 diabetes, GLP-1 agonists have gained significant attention for their potential in promoting weight loss and treating obesity

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al

Verify coverage with your insurer for branded products

Drug interactions are possible with prescription pain medications and other medications

The result is fewer side effects than the other GLP-1 agonists, along with more weight loss and better insulin control, Skelley notes

Gastrointestinal symptoms like nausea and vomiting are the primary reported effects